Adcock Ingram and Natco Pharma: A New Era Begins

Indian pharmaceutical group Natco Pharma has made an unexpected R75-a-share offer to the minority shareholders of Adcock Ingram. This signals the end of the South African company’s 75-year tenure on the Johannesburg Stock Exchange (JSE). The bid is a significant 44% premium on the last traded price. It is set to delist one of the country’s oldest public companies, placing it firmly in private hands.